Founded in 1908 and headquartered in Denmark, we are majority owned by the LEO Foundation
Dedicating decades of research and development to advance the science of dermatology
Advancing the standard of care for the benefit of people with skin conditions, their families and society
LEO Pharma delivered on strategic ambitions and showed resilience during COVID-19 pandemic in 2020
LEO Pharma net sales recovered from COVID-19 impact during the year, reaching DKK 10.1 billion (-6%).
Ballerup, Denmark, March 23, 2021Read the full story